• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present invention relates to methods of and devices for concentrating target cells using dielectrophoresis (DEP). In particular, the method allows relatively high throughput of sample (preferably using sample volumes of up to 100ml, or up to 10ml, or up to 1ml) through a microfluidic device in order to allow rapid capture of target cells even when they are present in low concentrations within the sample. The method utilises multiple chambers through which samples will flow, the chambers arranged such that the first capture area has a larger area and faster flow rate than a second chamber, the second chamber being positioned downstream of the first capture area and being smaller with a slower flow rate to further concentrate the material captured in the first capture area.
    公开号:EP3693087A1
    申请号:EP20167555.0
    申请日:2017-06-20
    公开日:2020-08-12
    发明作者:Jonathan O'halloran；Heather MURTON；Stephen Osborne；Eduardo Boada；Jonathan Salmon
    申请人:QUANTUMDX GROUP Ltd；
    IPC主号:B01L3-00
    专利说明:
    [0001] The present invention relates to methods of and devices for concentrating target cells using dielectrophoresis (DEP). In particular, the method allows relatively high throughput of sample (preferably using sample volumes of up to 100ml, or up to 10ml, or up to 1ml) through a microfluidic device in order to allow rapid capture of target cells even when they are present in low concentrations within the sample. The method utilises multiple areas or chambers through which samples will flow, the areas or chambers arranged such that the first capture area has a larger area and faster flow rate than a second chamber, the second chamber being positioned downstream of the first capture area and being smaller with a slower flow rate to further concentrate the material captured in the first capture area.
    [0002] Early detection of pathogens is key to effective and timely treatment in many cases. For example, Tuberculosis (TB) causes 2 million deaths per year, despite most cases being curable. With no effective vaccine available, early diagnosis and effective treatment are crucial to eliminating this disease. An estimated 60% of patients requiring a TB test present in local community-based health centres, however diagnostic testing for multi-drug resistant tuberculosis (MDR-TB) requires expensive and complex laboratory equipment and highly skilled staff found in referral or satellite laboratories. Results, including a panel of drug resistance markers, may not be returned for weeks during which time the infection can spread within the community.
    [0003] Advances in microfluidics are such that point of care (POC) diagnostic devices are moving closer to becoming a reality. However, there are still significant bottlenecks in the proposed POC systems, many of which relate to the pre-processing of samples for testing where samples with potentially low concentrations of pathogens must be processed to provide more concentrated volumes of pathogenic material. There are also challenges in processing relatively large volumes of sample in acceptable timeframes to be truly suitable for the provision of a point of care diagnosis.
    [0004] Dielectrophoresis (DEP) is where a force is exerted on a dielectric or polarisable particle, causing it to move, when it is subjected to a spatially nonuniform electric field. DEP motion can be induced toward an electrode surface (positive DEP) or away from an electrode surface (negative DEP).
    [0005] DEP can be used for microfluidic continuous flow processing of a sample potentially containing target cells to concentrate the target cells. A DEP electrode is tuned to selectively trap target cells suspended in a sample stream onto the designated area inside a microfluidic channel, whilst unwanted cells and material continue to be drawn through the microfluidic channel by the flow. This requires target specific DEP forces that are strong enough to continuously trap the cells against the hydrodynamic forces. DEP operation is effective for the trapping based cell separation and concentration because the target cells can be captured on the electrode's surfaces and can then be released by turning off the electric field.
    [0006] Whilst such an approach can be useful, it is currently limited in a clinical setting due to the speed of processing. Particularly in cases where the pathogen or target cell may be present only at very low concentrations in a sample, relatively high volumes of sample need to be flowed through the microfluidics system. If the sample is flowed through a typical DEP microfluidic system at too high a flow rate the efficiency of capture of target cells is reduced - without wishing to be limited by theory it is believed that the high flow rate is detrimental for the following reasons (i) some cells escape capture, as those further from the electrodes are subject to less force and therefore may be overcome by the hydrodynamic forces, (ii) that over time it effectively washes off previously trapped cells. Therefore DEP capture would need to be run slowly, adding significant time to the overall POC diagnostic process.
    [0007] The present invention aims to obviate or mitigate one or more of the drawbacks associated with the prior art.
    [0008] In accordance with a first aspect of the present invention there is provided a method for concentrating target particles in a sample, comprising the steps of; providing a microfluidic device, said device comprising;at least one first capture area comprising first means for selectively and releasably capturing target particles, such means arranged such that a sample flowing through the first capture area will flow over said means;a second area downstream of the first capture area and in fluid communication therewith, the second area being of smaller volume than the first capture area and comprising, a second means to capture target particles arranged such that a sample flowing through the second capture area will flow over them;introducing a sample into the first capture area and flowing the sample through the first capture area at a first flow rate, and with the first means for selectively and releasably capturing target cells able to trap any target particles;releasing trapped target particles from the first means for selectively and releasably capturing target particles to provide an enriched sample;introducing the enriched sample to the second chamber and flowing the enriched sample through the second chamber at a second flow rate which is lower than the first flow rate, and with the second means to capture target particles able to trap target particles;carrying out further processing steps.
    [0009] Preferably the target particles are target cells.
    [0010] Preferably the means for selectively and releasably capturing target cells is a plurality of electrodes, which, when activated, trap target cells at their surface.
    [0011] Preferably the second means capture target cells is a plurality of electrodes which, when activated, trap target cells at their surface.
    [0012] Surprisingly, the inventors have found that by flowing a sample through a first larger area, such as a chamber, chamber with DEP electrodes at a relatively high flow rate allows an initial quick capture, the captured cells can then be released which can then be followed by flowing the resulting enriched flow through a second smaller chamber at a lower flow rate than in the first capture area. This allows target cell to be concentrated efficiently and quickly (particularly as compared to the method of simply flowing through a channel with a DEP electrode). In particular this allows a relatively large sample volume to be processed in a time effective manner irrespective of whether there are high or low amounts of target present. Effectively the system allows for sample to flow with a higher mean velocity across the first area than the second area.
    [0013] Preferably the step of introducing a sample into the first capture area and flowing the sample through the first capture area at a first volumetric flow rate across said area, and with the first means for selectively and releasably capturing target cells able to trap any target cells, comprises introducing a sample into the first capture area and flowing the sample through the first capture area at a first flow rate, with the electrodes activated to trap any target cells. The electrodes are arranged to utlise DEP to selectively trap target cells.
    [0014] Preferably the step of releasing trapped target cells from the first means for selectively and releasably capturing target cells to provide an enriched sample comprises deactivating the electrodes in the first capture area after a period of time to release trapped target cells to provide an enriched sample.
    [0015] Preferably the step of introducing the enriched sample to the second chamber and flowing the enriched sample through the second chamber at a second volumetric flow rate across the second area which is lower than the first flow rate, and with the second means to capture target cells able to trap target cells comprises introducing the enriched sample to the second chamber and flowing the enriched sample through the second chamber at a second flow rate which is lower than the first flow rate, and with the electrodes activated to trap target cells. The electrodes are arranged to utlise DEP to selectively trap target cells.
    [0016] Preferably the at least one first capture area comprises at least one inlet and at least one outlet.
    [0017] Preferably, the second area comprises at least one inlet and at least one outlet. However the inlet an outlet may simply be formed from an area in a channel.
    [0018] It will be understood that references to an enriched sample or further enriched sample will only include target cells in that case that such cells are present in the original sample i.e. if the sample contains pathogen.
    [0019] Optionally the first capture area is a chamber.
    [0020] Optionally the second area is a chamber.
    [0021] Preferably, the at least one inlet of the first capture area is divided into multiple channels, where each channel is of smaller circumference than the at least one inlet of the first capture area.
    [0022] Preferably the multiple channels are multiple parallel channels.
    [0023] Advantageously, by dividing the first capture area into a plurality of, preferably parallel, smaller circumference channels this allows a relatively large volume of sample to be flowed with the characteristics of smaller volumes. As the first capture area is now effectively a capture area with plurality of channels the problems often associated with laminar flow characteristics where the center of the flow is typically faster than the edges is lessened. In particular problems associated with flow at the edges of the channels are mitigated and there are less issues with voltage drop across the electrodes.
    [0024] Preferably the multiple channels rejoin at the outlet of the at least one first capture area.
    [0025] Preferably the at least one inlet of the first capture area is provided with at least one bifurcation to divide it into multiple channels.
    [0026] Preferably the at least one outlet of the first capture area is provided with at least one bifurcation to rejoin it into a single channels.
    [0027] Advantageously using bifurcations to split the inlet channels or rejoin the outlet channels provides a reproducible and manageable way to step up or step down the pressure.
    [0028] Optionally, the microfluidic device may comprise a plurality of separable portions.
    [0029] Optionally, prior to deactivating the electrodes in the first capture area a new buffer or media is flowed into the first capture area. This new buffer could be water. When the electrodes are then deactivated the target cells are released into the new buffer to give an enriched sample with a higher concentration of target cells.
    [0030] Preferably the sample is low salt or low ionic strength.
    [0031] Optionally, further processing steps may include deactivating the electrodes in the second chamber after a period of time to release trapped target cells to provide a further enriched sample. Optionally, prior to deactivating the electrodes in the second chamber a new buffer or media is flowed into the first capture area. This new buffer could be water. When the electrodes are then deactivated the target cells are released into the new buffer to give a further enriched sample with a higher concentration of target cells.
    [0032] Optionally, further processing steps may include lysing the cells in situ and optionally carrying out nucleic acid extraction and/or amplification.
    [0033] Optionally, antibodies to the target cells may be introduced into the first capture area and/or the second chamber. Said antibodies may include fluorophores.
    [0034] Optionally, a biological stain specific to the target cells may be introduced into the first capture area and/or the second chamber.
    [0035] Optionally an optical detection device is provided.
    [0036] Preferably said optical detection device is arranged to detect signals from the second chamber. Preferably said optical detection device is capable of detecting, and preferably differentiating or analysing, fluorescence. Optionally the optical detection device comprises an excitation source and a detector.
    [0037] Optionally the device is provided with flow regulators. Optionally the flow regulators are pumps. Flow can be regulated in a number of ways as would be readily understood by one skilled in the art. Changes in flow can be achieved by changing the contours and sizes of the microfluidic channels and chambers and/or using additional means such as pumps.
    [0038] Preferably, when the electrodes in the first capture area are activated, the sample flows out of the capture area to a waste reservoir. Preferably, when the electrodes in the first capture area are deactivated, the sample flows out of the first capture area to the second chamber.
    [0039] Preferably, when the electrodes in the second chamber are activated, the sample flows out of the second chamber to a waste reservoir.
    [0040] According to a second aspect of the present invention there is provided a microfluidic device for concentrating target cells in a sample, comprising;a first capture area, the first capture area comprising at least one inlet and at least one outlet and further comprising, when in use, a plurality of electrodes which, when activated, trap target cells at their surface, said electrodes arranged such that a sample flowing through the first capture area will flow over them;a second chamber, downstream of the first capture area and in fluid communication therewith, the second chamber being of smaller volume than the first capture area and comprising at least one inlet and at least one outlet and further comprising, when in use, a plurality of electrodes which, when activated, trap target cells at their surface, said electrodes arranged such that a sample flowing through the first capture area will flow over them;an electrode control module to activate and deactivate electrodes;flow control means to allow flow rate through the second chamber to be lower than the flow rate through the first capture area.
    [0041] Preferably, the at least one inlet of the first capture area is divided into multiple channels, where each channel is of smaller circumference than the at least one inlet of the first capture area.
    [0042] Preferably the multiple channels are multiple parallel channels.
    [0043] Preferably the multiple channels rejoin at the outlet of the at least one first capture area.
    [0044] Preferably the at least one inlet of the first capture area is provided with at least one bifurcation to divide it into multiple channels.
    [0045] Preferably the at least one outlet of the first capture area is provided with at least one bifurcation to rejoin it into a single channels.
    [0046] Optionally, the microfluidic device may comprise a plurality of separable portions.
    [0047] Optionally, the device comprises a new buffer or media reservoir in fluid communication with the first capture area. Optionally the new buffer or media reservoir is in fluid communication with the second chamber. Alternatively a second new buffer or media reservoir is in fluid communication with the second chamber. Optionally the new buffer or media is water. The device may further comprise a control module that introduces flow of new buffer or media into the first capture area and/or second chamber when the electrodes are deactivated.
    [0048] Optionally, the device comprises a reservoir of antibodies to the target cells. Optionally the reservoir of antibodies is in fluid communication
    [0049] Optionally, a biological stain specific to the target cells may be introduced into the first capture area and/or the second chamber.
    [0050] Optionally an optical detection device is provided.
    [0051] Preferably said optical detection device is arranged to detect signals from the second chamber. Preferably said optical detection device is capable of detecting, and preferably differentiating or analysing, fluorescence. Optionally the optical detection device comprises an excitation source and a detector.
    [0052] Optionally the device comprises pre-processing modules. This may include additional chambers in fluid communication with the first capture area to pre-process the sample. This could include altering the viscosity of the sample, salt content etc.
    [0053] Optionally the device is provided with flow regulators. Optionally the flow regulators are pumps.
    [0054] Preferably the device is provided with a waste reservoir. Optionally the waste reservoir is in fluid communication with the first capture area. Preferably the waste reservoir is in fluid communication with the second chamber.
    [0055] A preferred variant of the first aspect aspect of the invention is a method for concentrating target cells, comprising the steps of;providing a microfluidic device, said device comprising;a first capture area, the first capture area comprising a plurality of electrodes which, when activated, trap target cells at their surface, said electrodes arranged such that a sample flowing through the first capture area will flow over them;a second capture area downstream of the first capture area and in fluid communication therewith, the second capture area being of smaller volume than the first capture area and comprising a plurality of electrodes which, when activated, trap target cells at their surface, said electrodes arranged such that a sample flowing through the first capture area will flow over them;introducing a sample into the first capture area and flowing the sample through the first capture area at a first flow rate, and with the electrodes activated to trap any target cells;deactivating the electrodes in the first capture area after a period of time to release trapped target cells to provide an enriched sample;introducing the enriched sample to the second chamber and flowing the enriched sample through the second capture area at a second flow rate which is lower than the first flow rate, and with the electrodes activated to trap target cells.
    [0056] In order to provide a better understanding of the present invention, embodiments will be described, by way of example only, and with reference to the following drawings;Figure 1 shows an embodiment of a microfluidic device, or portion thereof, in accordance with an embodiment of the present invention; Figure 2 shows another embodiment of a microfluidic device or portion thereof, in accordance with the present invention; Figure 3a shows an alternative embodiment of a device according to the present invention with 3b showing a larger view of the first capture area in said device which includes bifurcated channels in accordance with the present invention; and Figure 4 shows another embodiment of the device with a further variant of the first capture area having bifurcated channels where the design is such that there are in fact multiple first capture areas.
    [0057] A microfluidic device 1 (or portion thereof) is generally depicted in figure 1. The device comprises a first capture area 2 in the form of a chamber with a first inlet 3 through which fluid can flow into the first capture area 2, and a first outlet 4 through which fluid can leave the first capture area 2. The first capture area comprises a plurality of electrodes 5 arranged such that sample will flow over them or come into contact with them when the device is in use. The electrodes 5 are tuned appropriately, as would be understood by one skilled in the art, to trap target cells using DEP when the electrodes are activated. For example in some cases electrodes can use 10MHz, 5V for M. Smegmatis, but actually can work over a whole range of frequencies and voltages depending on flow-rates and electrode geometries.
    [0058] The device also comprises a second chamber 6, which is both downstream of and in fluid communication with the first capture area 2. There is a second chamber inlet 7 through which fluid can flow into the second chamber 6, and a second chamber outlet 8 through which fluid can leave the second chamber 6. The second chamber comprises a plurality of electrodes 5a arranged such that sample will flow over them or come into contact with them when the device is in use. The electrodes 5a are tuned appropriately, as would be understood by one skilled in the art, to trap target cells using DEP when the electrodes are activated.
    [0059] In use, a sample is introduced into the first capture area 2 at a first flow rate. The flow rate is regulated by a pump (not shown). The electrodes 5 are activated and as such, target cells (e.g. M. Tuberculosis cells or Mycobacterium smegmatis cells) in the sample are trapped by DEP forces at least part of the surface of the electrodes 5. The sample continues to flow through the chamber such that target cells continue to be captured whilst the remaining sample eluate from which the target cells have been removed travels to a waste reservoir 9 or other area. After a period of time, which may be a pre-determined period of time, the electrodes 5 are deactivated and the trapped target cells are released from the surface of the electrodes. This results in the media in through the first capture area 2 becoming enriched with target cells (providing, of course, that said target cells were in fact present in the original sample). This is referred to herein as the enriched sample.
    [0060] The enriched sample is then flowed through a channel, in this example a microfluidic channel, into the second chamber 6. The flow through the second chamber 6 is at a second flow rate that is lower than the flow rate of the sample through the first capture area 2. The electrodes 5a in the second chamber 6 are activated and as such, target cells (e.g. M. Tuberculosis cells or Mycobacterium smegmatis cells) in the sample are again trapped by DEP forces at least part of the surface of the electrodes 5a. As the enriched sample will already contain more concentrated volumes of target cells the capture or trapping of the target cells is highly effective.
    [0061] There is also provided a waste reservoir 9 which could be external to the device in the form of a waste bottle. The first capture area 2 and the second chamber 6 are both in fluid communication with a waste reservoir 9 to allow sample from which the cells have been removed, or unwanted flow through, to be removed. However one skilled in the art would appreciate that this conformation is not essential to the invention.
    [0062] It would be understood by one skilled in the art that various pre-processing steps and modules can be included prior to the sample being introduced into the first capture area.
    [0063] It would also be understood by one skilled in the art that various post-processing steps and modules can be included after the target cells are trapped or captured from the enriched sample in the second chamber. For example, the cells could be lysed in situ and then the nucleic acids extracted, enriched or amplified. Also, the electrodes in the second chamber could be deactivated and the target cells released to give a further concentrated sample.
    [0064] It would be understood by one skilled in the art that whist a first capture area and second chamber are described; additional concentrating chambers could also be included. Whilst the first and second chamber are in fluid communication, other modules, reservoirs and microfluidic structures could be included between the chambers.
    [0065] As best shown in Figure 2, an antibody reservoir 10 can be included, the antibodies being selected to bind to the cells of interest and either being provided with or being associable with a fluorophore or other marker. One skilled in the art would appreciate that the antibody reservoir 10 could be replaced with a biological dye, stain or other product which would allow identification of target cells during later processing. A system of valves 11 can be used to introduce the antibody into the first capture area 2' or second chamber 6' as required.
    [0066] The second chamber 6' is provided with either an open top or visually clear upper surface. This is so that, in use, the second chamber 6' can be associated with, or viewed using, an optical detection device (not shown) which is arranged to detect signals from the second chamber. Preferably said optical detection device is capable of detecting, and preferably differentiating or analysing, fluorescence. In this case the optical detection device would comprises an excitation source and a detector.
    [0067] Further, and often preferred embodiments are shown in Figures 3 and 4.
    [0068] In each of these embodiments there is provided a cassette device 1', 1" which has a first capture area 2', 2" positioned upstream from a second capture area 6', 6". The cassette is formed on a glass substrate (although it will be appreciated that other materials could also be used).
    [0069] In figure 3a, the first capture area comprises a plurality of electrodes 5' arranged such that sample will flow over them or come into contact with them when the device is in use (as shown more clearly in expanded figure 3b). The electrodes 5' are tuned appropriately, as would be understood by one skilled in the art, to trap target cells using DEP when the electrodes are activated. For example, in some cases electrodes can use 10MHz, 5V for M. Smegmatis, but actually can work over a whole range of frequencies and voltages depending on flow-rates and electrode geometries.
    [0070] The first inlet 3' leads into the first capture area. In the embodiment shown in Fig 3 the channel flowing from the inlet 3' is provided with bifurcations 13', each bifurcated channel is then provided with further bifurcations such that the inlet effectively leads to a plurality parallel channels 14" of smaller circumference than the initial channel. The number of bifurcations can be selected dependent on the required fluid flow. The plurality of parallel channels 14' each flow across the chamber and the electrodes 5' therein. Effectively, in this embodiment, the chamber is in fact a plurality of channels 14' that allow fluid to flow across electrodes, rather than a single open chamber. This allows the fluid flow to be managed. The channels 14' then flow through a reversed version of the bifurcations to ultimately re-join together. Each bifurcation at the inlet end reduces the height, width, or circumference of the channel that leads into it which allows for a large volume sample to be introduced through the inlet 3' and flowed across the first capture area 2' with manageable flow characteristics. Conversely, each bifurcation at the outlet end may increase in height and width, or circumference, compared to the individual channels that lead into it.
    [0071] Efficient dielectrophoretic immobilisation of target sequences required a tuned interaction with the field. Perturbations in flow velocity may alter the response of the target to the field and as such flow velocity must be carefully controlled. To ensure consistent and controlled flow velocity while maintaining high throughput volumes, narrow parallel chambers are required to reduce the effect of varying velocities and possible bubble formation. Within larger channels, flow velocity in the centre regions is significantly faster and as such capture cannot be optimised across the device. The use of bifurcation to equally split flow across multiple smaller channels allows greater control of flow velocities for optimised DEP capture.
    [0072] In the embodiment shown in Fig 4 the parallel channel concept has been further developed to allow for relatively rapid flow-through of sample in a relatively small footprint. In this embodiment, the substrate is glass and there are a plurality of layers sandwiched together to form the slide or cassette device 1". Providing the substrate as a plurality of layers allows channels to be formed in the layers at different depths that can be particularly useful when engineering the substrate as it allows for easier manufacturing. Some channels can be created at least partially in more than one layer. This can be seen in Fig 4 where the flow from the inlet 3" is shown as a block whit colour and is created in an upper layer which then feeds into channels in a lower layer (indicated in Fig 4 with parallel lines) at the first bifurcation (in Figure 4 it should be understood that the first bifurcation does allow fluid flow and the solid line shown in the figure is simply indicative of a change to different layers). The inlet 3" is again configured to have bifurcations 13" splitting the channel into two channels and then further bifurcations result in a plurality of channels 14". The channel that is immediately downstream of the inlet 3" is a relatively deep channel that extends through a plurality of layers of the substrate (or through a layer of the substrate to a depth X), however after the initial bifurcation, further channel bifurcations result in the channels becoming smaller, and these smaller channels are formed in a lesser number of substrate layers (or through a different layer of the substrate to a depth >X), typically in the mid-layer of the substrate.
    [0073] In this embodiment, the positioning of the channels is such that they do not initially all run parallel but do lead to a plurality of groups of parallel channels 14" of smaller circumference downstream of the inlet 3". Again, the plurality of parallel channels 14" each flow across electrodes therein. Flow can be directed by configuring the channels such that it can flow through multiple first capture areas 2" as shown here. In addition, the device 1" can be multilayered such that the channel depth can be configured easily. A multilayer channel configuration allows for different channels depths leading to the bifurcation zone. It can also allow for a smaller footprint as channels can run in different planes. In this way, pressure is consistently reduced and minimised inside the main capture channels.
    [0074] The device also comprises a second area 6", which is downstream of and in fluid communication with the first capture area(s) 2" (or chamber(s) 2"). There may be a waste outlet provided between the first area 2" and second area 6" which can be provided with a valve, such that when the valve is in a first position, e.g. open, flow is directed through a waste outlet 12" to a waste chamber or area, and when in a second position, e.g. closed, flow does not exit via the waste outlet and instead is directed to the second area.
    [0075] There may be a second chamber inlet through which fluid (being the low volume enriched sample) can flow into the second chamber 6" or it may simply be that the second area is positioned downstream and in the fluid flow channel. There may also be a second chamber outlet 8" through which fluid can leave the second area 6". The second area comprises a plurality of electrodes 5a" arranged such that enriched sample will flow over them or come into contact with them when the device is in use. The electrodes 5a are tuned appropriately, as would be understood by one skilled in the art, to trap target cells using DEP when the electrodes are activated.
    [0076] In use, a sample is introduced into the first capture area 2" at a first flow rate. The flow rate is regulated by a pump (not shown). The electrodes 5" are activated and as such, target cells (e.g. M. Tuberculosis cells or Mycobacterium smegmatis cells) in the sample are trapped by DEP forces at least part of the surface of the electrodes 5". The sample continues to flow through the chamber 2" such that target cells continue to be captured whilst the remaining sample eluate from which the target cells have been removed travels via the waste outlet 12" to a waste reservoir or other area. After a period of time, which may be a pre-determined period of time, the electrodes 5" are deactivated and the trapped target cells are released from the surface of the electrodes". This results in the media in the first capture area 2" becoming enriched with target cells (providing, of course, that said target cells were in fact present in the original sample). This is referred to herein as the enriched sample.
    [0077] The enriched sample does not flow to the waste chamber but instead is then flowed through a channel, in this example a microfluidic channel, into the second chamber or area 6". The flow through the second chamber 6" is at a second flow rate that is lower than the flow rate of the sample through the first capture area 2".
    [0078] Further details of the present invention are provided in the following numbered clauses:1. In accordance with a first aspect of the present invention there is provided a method for concentrating target particles in a sample, comprising the steps of;providing a microfluidic device, said device comprising;at least one first capture area comprising a first means for selectively and releasably capturing target particles, such means arranged such that a sample flowing through the first capture area will flow over said means;a second area downstream of the first capture area and in fluid communication therewith, the second area being of smaller volume than the first capture area and comprising, a second means to capture target particles arranged such that a sample flowing through the second capture area will flow over them;introducing a sample into the first capture area and flowing the sample through the first capture area at a first flow rate, and with the first means for selectively and releasably capturing target particles arranged to trap any target particles;releasing trapped target particles from the first means for selectively and releasably capturing target particles to provide an enriched sample;introducing the enriched sample to the second chamber and flowing the enriched sample through the second chamber at a second flow rate which is lower than the first flow rate, and with the second means to capture target particles able to trap target particles;carrying out further processing steps. 2. A method for concentrating target particles as in clause 1 wherein the means for selectively and releasably capturing target particles is a plurality of electrodes, which, when activated, trap target particles at their surface. 3. A method for concentrating target particles as in clauses 1 or 2 wherein the second means capture target particles is a plurality of electrodes, which, when activated, trap target particles at their surface. 4. A method for concentrating target particles as in any of clauses2 or 3 wherein the step of introducing a sample into the first capture area and flowing the sample through the first capture area at a first flow rate with the first means for selectively and releasably capturing target particles arranged to capture said particles, comprises introducing a sample into the first capture area and flowing the sample through the first capture area at a first flow rate, and with the electrodes activated to trap any target particles. 5. A method for concentrating target particles as in clause 4 wherein the step of releasing trapped target particles from the first means for selectively and releasably capturing target particles to provide an enriched sample comprises deactivating the electrodes in the first capture area after a period of time to release trapped target particles to provide an enriched sample. 6. A method for concentrating target particles as in any of clauses 2 to 5 wherein the step of introducing the enriched sample to the second chamber and flowing the enriched sample through the second chamber at a second flow rate which is lower than the first flow rate, with the second means to capture target cells able to trap target particles, comprises introducing the enriched sample to the second chamber and flowing the enriched sample through the second chamber at a second flow rate which is lower than the first flow rate, and with the electrodes activated to trap target particles. 7. A method for concentrating target particles as in any of the previous clauses wherein the at least one inlet of the first capture area is divided into multiple channels, where each channel is of smaller circumference than the at least one inlet of the first capture area. 8. A method for concentrating target particles as in clause 7 wherein the multiple channels are multiple parallel channels. 9. A method for concentrating target particles as in any of clauses 7 or 8 wherein the multiple channels rejoin at the outlet of the at least one chamber. 10. A method for concentrating target particles as in any of clauses 7 to 9 wherein the at least one inlet of the first capture area is provided with at least one bifurcation to divide it into multiple channels. 11.A method for concentrating target particles as in any of clauses 7 to 10 wherein the at least one outlet of the first capture area is provided with at least one bifurcation to rejoin it into a single channels. 12.A method for concentrating target particles as in any of the previous clauses wherein the microfluidic device comprises a plurality of separable portions. 13.A method for concentrating target particles as in any of the previous clauses wherein, prior to releasing the trapped target particles in the first capture area, a new buffer or media is flowed into the first capture area. 14. A method for concentrating target particles as in clause 13 wherein the new buffer is water. 15.A method for concentrating target particles as in any of the previous clauses wherein the sample is low salt or low ionic strength. 16. A method for concentrating target particles as in any of clauses 2 to 15 wherein further processing includes deactivating the electrodes in the second chamber after a period of time to release trapped target cells to provide a further enriched sample. 17.A method for concentrating target particles as in clause 16 wherein, prior to deactivating the electrodes in the second chamber a new buffer or media is flowed into the first capture area. 18.A method for concentrating target particles as in any of the previous clauses wherein further processing steps include carrying out nucleic acid extraction and/or amplification. 19.A method for concentrating target particles as in any of the previous clauses wherein antibodies to the target particles are introduced into the first capture area and/or the second chamber. 20.A method for concentrating target particles as in any of the previous clauses wherein a biological stain specific to the target particles is introduced into the first capture area and/or the second chamber. 21.A method for concentrating target cells as in any of the previous clauses wherein an optical detection device is provided and target particles are viewed using the same. 22.A method for concentrating target particles as in clause 21 wherein said optical detection device is arranged to detect signals from the second chamber. 23.A method for concentrating target particles as in any of clauses 21 or 22 wherein said optical detection device is capable of detecting, and preferably differentiating or analysing, fluorescence. 24.A method for concentrating target particles as in any of clauses 21 to 23 wherein the optical detection device comprises an excitation source and a detector. 25.A method for concentrating target particles as in any of the previous clauses wherein the device is provided with flow regulators which may be pumps. 26.A method for concentrating target cells as in any of the previous clauses wherein, when the electrodes in the first capture area are capturing target particles, the sample flows out of the chamber to a waste reservoir. 27.A microfluidic device for concentrating target particles, such as target cells, in a sample, comprising;a first capture area, the first capture area comprising a first means for selectively and releasably capturing target particles, said means arranged such that a sample flowing through the first capture area will flow over said means;a second chamber, downstream of the first capture area and in fluid communication therewith, the second chamber being of smaller volume than the first capture area and comprising a second means to capture target particles arranged such that a sample flowing through the second capture area will flow over said means;a control module;flow control means to allow flow rate through the second chamber to be lower than the flow rate through the first capture area. 28.A microfluidic device as in clause 27 wherein the first means for selectively and releasably capturing target particles is a plurality of electrodes, which, when activated, trap target cells at their surface. 29.A microfluidic device as in any of clauses 27 or 28 wherein the second means to capture target particles, is a plurality of electrodes which, when activated, trap target cells at their surface. 30.A microfluidic device as in any of clauses 28 or 29 wherein said control module controls the activation and deactivation of the electrodes. 31.A microfluidic device as in any of clauses 27 to 30 wherein the inlet of the first capture area is divided into multiple channels, where each channel is of smaller circumference than the at least one inlet of the first capture area. 32.A microfluidic device as in clause 31 wherein the multiple channels are multiple parallel channels. 33.A microfluidic device as in any of clauses 31 to 32 wherein the multiple channels rejoin at the outlet of the first capture area. 34.A microfluidic device as in any of clauses 31 to 33 wherein the inlet of the first capture area is provided with at least one bifurcation to divide it into multiple channels. 35.A microfluidic device as in any of clauses 31 to 34 wherein the outlet of the first capture area is provided with at least one bifurcation to rejoin it into a single channels. 36.A microfluidic device as in any of clauses 28 to 35 wherein the device comprises a control module that introduces flow of new buffer or media into the first capture area and/or second chamber when the electrodes in said capture area or chamber are deactivated. 37.A microfluidic device as in any of clauses 27 to 36 comprising an optical detection device. 38.A microfluidic device as in clauses 37 wherein said optical detection device is arranged to detect signals from the second chamber. 39.A microfluidic device as in any of clauses 37 or 38 wherein said optical detection device is capable of detecting, and preferably differentiating or analysing, fluorescence. 40.A microfluidic device as in any of clauses 37 to 38 wherein the optical detection device comprises an excitation source and a detector. 41.A microfluidic device as in any of clauses 27 to 40 wherein the device comprises pre-processing modules. 42.A microfluidic device as in any of clauses 27 to 41 wherein the device is provided with a waste reservoir. 43.A microfluidic device as in clause 46 wherein the waste reservoir is in fluid communication with the first capture area and/or the second chamber.
    [0079] Although the above preferred embodiments describe methods and devices which use electrodes and di-electrophoresis to capture and enrich target cells, it could be envisaged that alternative means for capturing target particles, which are typically cells, could be employed providing they are both selective and able to release any captured particles when required i.e. the binding or capture of cells or particles is reversible. The release could for example use light or chemical changes rather than electrical changes.
    [0080] It will be appreciated that features from one embodiment may be appropriately incorporated into another embodiment unless technically unfeasible to do so.
    [0081] With respect to the use of substantially any plural and/or singular terms herein, those having skill in the art can translate from the plural to the singular and/or from the singular to the plural as is appropriate to the context and/or application. The various singular/plural permutations may be expressly set forth herein for sake of clarity.
    [0082] It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims are generally intended as "open" terms (e.g., the term "including" should be interpreted as "including but not limited to," the term "having" should be interpreted as "having at least," the term "includes" should be interpreted as "includes but is not limited to," etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases "at least one" and "one or more" to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles "a" or "an" limits any particular claim containing such introduced claim recitation to embodiments containing only one such recitation, even when the same claim includes the introductory phrases "one or more" or "at least one" and indefinite articles such as "a" or "an" (e.g., "a" and/or "an" should be interpreted to mean "at least one" or "one or more"); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should be interpreted to mean at least the recited number (e.g., the bare recitation of "two recitations," without other modifiers, means at least two recitations, or two or more recitations).
    [0083] It will be appreciated that various embodiments of the present disclosure have been described herein for purposes of illustration, and that various modifications may be made without departing from the scope and spirit of the present disclosure. Accordingly, the various embodiments disclosed herein are not intended to be limiting, with the true scope and spirit being indicated by the following claims.
    权利要求:
    Claims (15)
    [0001] A microfluidic device for concentrating target cells, characterised in that the device comprises:
    a first capture area through which a sample can be flowed, said first capture area comprising a plurality of electrodes tuned to trap said target cells using di-electrophoresis (DEP) when activated, and to release said target cells when de-activated, said electrodes arranged such that a sample flowing through the area will flow over them;
    a waste area downstream of the first capture area and in fluid communication with said first capture area;
    a second capture area downstream of the first capture area and in fluid communication with said first area, said second capture area being of a smaller volume than the first capture area and comprising a plurality of electrodes tuned to trap target cells using di-electrophoresis (DEP), said electrodes arranged such that a sample flowing through the second area will flow over them;
    one or more flow regulators adapted to ensure that the volumetric flow rate of sample travelling through the second capture area is lower than the volumetric flow rate of sample travelling through the first capture area;
    the device arranged such that when the electrodes tuned to trap said target cells using di-electrophoresis (DEP) in the first capture area are activated sample flows out from the first capture area to the waste area, and when the electrodes tuned to trap said target cells using di-electrophoresis (DEP) in the first capture area are de-activated sample flows out from the first capture area to the second capture area.
    [0002] A microfluidic device as in Claim 1 wherein the first capture area is divided into multiple channels.
    [0003] A microfluidic device as in any of Claims 1 or 2 wherein the device comprises a control module that introduces flow of new buffer or media into the first capture area and/or second area when the electrodes in said first capture area or second area are deactivated.
    [0004] A microfluidic device as in any of the previous Claims comprising an optical detection device.
    [0005] A microfluidic device as in Claim 4 wherein said optical detection device is arranged to detect signals from the second area.
    [0006] A microfluidic device as in any of the previous Claims wherein the waste area is a waste reservoir.
    [0007] A microfluidic device as in any of the previous Claims wherein the flow regulators are pumps.
    [0008] A method for concentrating target particles in a sample, comprising the steps of;providing a microfluidic device of the previous claims;introducing a sample into the first capture area and flowing the sample through the first capture area at a first flow rate, and with the first plurality of electrodes activated and arranged to trap any target particles,and with the sample flow being directed out from the first capture area to the waste area;de-activating the first plurality of electrodes and releasing trapped target particles from said first plurality of electrodes to provide an enriched sample, and also directing sample flow being out from the first capture area to the second area;introducing the enriched sample to the second area and flowing the enriched sample through the second area at a second flow rate which is lower than the first flow rate, and with the second plurality of electrodes arranged and activated to trap target particles
    [0009] A method for concentrating target particles as in claim 8, wherein the step of releasing trapped target particles from the first plurality of electrodes to provide an enriched sample comprises deactivating the electrodes in the first capture area after a defined period of time to release trapped target particles to provide an enriched sample.
    [0010] A method for concentrating target particles as in any of claims 8 or 9 wherein, prior to releasing the trapped target particles in the first capture area, a new buffer or media is flowed into the first capture area.
    [0011] A method for concentrating target particles as in any of Claims 8 to 10 wherein the sample is low salt or low ionic strength.
    [0012] A method for concentrating target particles as in any of Claims 8 to 11 wherein the method includes the further step of deactivating the electrodes in the second area after a period of time to release trapped target cells to provide a further enriched sample.
    [0013] A method for concentrating target particles as in Claim 12 wherein, prior to deactivating the electrodes in the second area a new buffer or media is flowed into the second area.
    [0014] A method for concentrating target cells as in any of Claims 8 to 13 wherein an optical detection device is provided, and target particles are viewed using the optical detection device.
    [0015] A method for concentrating target particles as in Claim 14 wherein said optical detection device is arranged to detect signals from the second area.
    类似技术:
    公开号 | 公开日 | 专利标题
    US10478819B2|2019-11-19|Sorting particles in a microfluidic device
    US9533305B2|2017-01-03|Systems and methods for automated reusable parallel biological reactions
    US10407709B2|2019-09-10|Method and device for isolating cells from heterogeneous solution using microfluidic trapping vortices
    US10078066B2|2018-09-18|Devices and methods for contactless dielectrophoresis for cell or particle manipulation
    Yang et al.2017|Exosome separation using microfluidic systems: size‐based, immunoaffinity‐based and dynamic methodologies
    US10174305B2|2019-01-08|Microfluidic droplet encapsulation
    Zhang et al.2014|Inertial particle separation by differential equilibrium positions in a symmetrical serpentine micro-channel
    Li et al.2014|A review of microfabrication techniques and dielectrophoretic microdevices for particle manipulation and separation
    Sollier et al.2014|Size-selective collection of circulating tumor cells using Vortex technology
    Liu et al.2013|Rapid isolation of cancer cells using microfluidic deterministic lateral displacement structure
    AU2015249293B2|2020-06-25|DEP force control and electrowetting control in different sections of the same microfluidic apparatus
    Hajba et al.2014|Circulating tumor-cell detection and capture using microfluidic devices
    Cima et al.2013|Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives
    TWI691724B|2020-04-21|Apparatus for detecting particle in fluid sample and method for isolating aliquot of fluid sample within microfluidic chip
    Hou et al.2011|Microfluidic devices for blood fractionation
    US9789485B2|2017-10-17|Micro-fluidic device and uses thereof
    Chang et al.2015|Circulating tumor cell detection using a parallel flow micro-aperture chip system
    Chiriacò et al.2018|Lab-on-chip for exosomes and microvesicles detection and characterization
    Shields IV et al.2015|Microfluidic cell sorting: a review of the advances in the separation of cells from debulking to rare cell isolation
    Cummings et al.2003|Dielectrophoresis in microchips containing arrays of insulating posts: theoretical and experimental results
    AU2011222582B2|2015-10-15|Microfluidics sorter for cell detection and isolation
    Kersaudy-Kerhoas et al.2008|Recent advances in microparticle continuous separation
    EP2378268B1|2013-06-05|Particle separation and concentration system
    US10718007B2|2020-07-21|System and method for capturing and analyzing cells
    Chen et al.2008|Microfluidic chip for blood cell separation and collection based on crossflow filtration
    同族专利:
    公开号 | 公开日
    JP6641032B2|2020-02-05|
    JP2019525739A|2019-09-12|
    PL3471879T3|2020-11-16|
    JP2020099325A|2020-07-02|
    EP3471879A1|2019-04-24|
    US20200298235A1|2020-09-24|
    US10710075B2|2020-07-14|
    US20190176151A1|2019-06-13|
    WO2017220534A1|2017-12-28|
    EP3471879B1|2020-05-13|
    ES2802261T3|2021-01-18|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    法律状态:
    2020-07-10| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
    2020-07-10| PUAI| Public reference made under article 153(3) epc to a published international application that has entered the european phase|Free format text: ORIGINAL CODE: 0009012 |
    2020-08-12| AK| Designated contracting states|Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
    2020-08-12| AC| Divisional application: reference to earlier application|Ref document number: 3471879 Country of ref document: EP Kind code of ref document: P |
    2021-02-05| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
    2021-03-10| RBV| Designated contracting states (corrected)|Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
    2021-03-10| 17P| Request for examination filed|Effective date: 20210201 |
    2021-04-11| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: GRANT OF PATENT IS INTENDED |
    2021-04-11| GRAP| Despatch of communication of intention to grant a patent|Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
    2021-04-30| REG| Reference to a national code|Ref country code: HK Ref legal event code: DE Ref document number: 40034581 Country of ref document: HK |
    2021-05-05| INTG| Intention to grant announced|Effective date: 20210412 |
    2021-07-27| GRAS| Grant fee paid|Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
    2021-07-30| GRAA| (expected) grant|Free format text: ORIGINAL CODE: 0009210 |
    2021-07-30| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
    2021-09-01| AK| Designated contracting states|Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
    2021-09-01| AC| Divisional application: reference to earlier application|Ref document number: 3471879 Country of ref document: EP Kind code of ref document: P |
    2021-09-01| REG| Reference to a national code|Ref country code: GB Ref legal event code: FG4D |
    2021-09-15| REG| Reference to a national code|Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 1425633 Country of ref document: AT Kind code of ref document: T Effective date: 20210915 |
    2021-09-23| REG| Reference to a national code|Ref country code: DE Ref legal event code: R096 Ref document number: 602017045515 Country of ref document: DE |
    2021-09-29| REG| Reference to a national code|Ref country code: IE Ref legal event code: FG4D |
    2021-11-30| REG| Reference to a national code|Ref country code: SE Ref legal event code: TRGR |
    2021-12-08| REG| Reference to a national code|Ref country code: NL Ref legal event code: FP |
    2021-12-27| REG| Reference to a national code|Ref country code: LT Ref legal event code: MG9D |
    2022-01-31| PG25| Lapsed in a contracting state [announced via postgrant information from national office to epo]|Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210901 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210901 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210901 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210901 |
    2022-02-15| REG| Reference to a national code|Ref country code: AT Ref legal event code: MK05 Ref document number: 1425633 Country of ref document: AT Kind code of ref document: T Effective date: 20210901 |
    2022-02-28| PG25| Lapsed in a contracting state [announced via postgrant information from national office to epo]|Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210901 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210901 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211202 |
    优先权:
    申请号 | 申请日 | 专利标题
    [返回顶部]